Novel antithrombotic approaches to coronary artery disease

This publication has 12 references indexed in Scilit:

• Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.
  Circulation, 1994
• A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial
  Journal of the American College of Cardiology, 1994
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
  The Lancet, 1994
• Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis.
  Circulation, 1994
• Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
  Circulation, 1994
• Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.
  Circulation, 1994
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  BMJ, 1994
• Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects.
  Circulation, 1993
• Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab thrombolytic therapy: Results of the thrombolysis and angioplasty in mycardial infaraction (TAMI) 8 pilot study
  Journal of the American College of Cardiology, 1993
• Reversible Tripeptide Thrombin Inhibitors as Adjunctive Agents to Coronary Thrombolysis
  Journal of Cardiovascular Pharmacology, 1993